Filters: author is Soudijn [Clear All Filters]
- 1996
Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo,
Br J Pharmacol, vol. 118, no. 2, pp. 369-77.
Partial agonism of the nonselective adenosine receptor agonist 8-butylaminoadenosine at the A1 receptor in vivo,
J Pharmacol Exp Ther, vol. 279, no. 3, pp. 1439-46.
- 1995
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor,
J Med Chem, vol. 38, no. 20, pp. 4000-6.
Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo,
Br J Pharmacol, vol. 116, no. 3, pp. 1957-64.
Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine,
J Pharmacol Exp Ther, vol. 275, no. 1, pp. 245-53.
Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats,
Br J Pharmacol, vol. 114, no. 4, pp. 761-8.
Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of R- and S-N6-phenylisopropyladenosine in conscious normotensive rats,
J Pharmacol Exp Ther, vol. 273, no. 1, pp. 405-14.
- 1994
Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat,
J Pharmacol Exp Ther, vol. 268, no. 2, pp. 616-24.
- 1993
